Italian Network on Congestive Heart Failure: Ten-year experience;IN-CHF: Il registro italiano dello scompenso cardiaco. Dieci anni di esperienza

Giornale Italiano di Cardiologia

Volumn 7, Issue 10, 2006, Pages 689-694

  Fabbri, Gianna ^c   Gorini, Marco ^c   Maggioni, Aldo P ^b   Cacciatore, Giuseppe ^a   Di Lenarda, Andrea ^a  

^a Area ScompensoANMCO   (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

^c NONE

Author keywords

Heart failure; Network

Indexed keywords

CREATININE; HEMOGLOBIN;

ANEMIA; ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DATA BASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; EXPERIENCE; FOLLOW UP; HEALTH CENTER; HEART ATRIUM FIBRILLATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART SOUND; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; ITALY; KIDNEY DYSFUNCTION; LUNG DISEASE; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; OUTPATIENT; PATIENT CARE; PRACTICE GUIDELINE; PUBLISHING; REGISTER; TREATMENT OUTCOME;

AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; ITALY; MALE; REGISTRIES; SOFTWARE; TIME FACTORS;

EID: 33845428808     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. From AM, Leibson CL, Bursi F, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006; 119: 591-9.
2. Maggioni AP, Opasich C, Anand C, et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Cardiac Fail 2005; 11: 91-8.
3. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds. The TEMISTOCLE study. Am Heart J 2003; 146: e12.
4. Bristow MR, Saxon LA, Boehmer J. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
5. Cleland JG, Daubert JC, Erdmann E, et al, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. Effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
6. Baldasseroni S, De Biase S, Fresco C, et al, for the Italian Network on Congestive Heart Failure. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (IN-CHF database). Eur Heart J 2002; 23: 1692-8.
7. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J 2002; 143: 398-405.
8. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trial. Heart 2000; 21: 2071-8.
9. Desai AS, Fang JC, Maisel WH, Baugham KL. Implantable defibrillators for the prevention of mortality in patents with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004; 292: 2874-9.
10. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Hearth Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
11. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation; endorsed by the Heart Rhythm Society. Circulation 2005; 112: 1825-52.
12. Wilber DJ, Zareba W, Hall J, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004; 109: 1082-4.
13. Adams KF, Fonarow GG, Emerman CL, et al, for the ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalised for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-16.
14. Cleland JGF, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-63.